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Abstract
Atherosclerosis is a progressive disease that leads to plaque development and is associated with
cardiovascular events such as myocardial infarction and stroke. Several biomarkers have been
established as surrogates of plaque development yet none can provide direct, noninvasive, rapid
measurements of atherosclerotic disease. Three-dimensional Ultrasound (3DUS) image acquisition
is safe, inexpensive and fast, however 3DUS image measurements are limited due to time
consuming manual image analyses. In addition, the true clinical meaning of 3DUS carotid imaging
measurements has not yet been established. A semi-automated approach for the estimation of 3DUS
Total Plaque Volume (TPV) was developed with similar variability and high agreement with
manual measurements. 3DUS measurements such as Vessel Wall Volume (VWV) and TPV were
shown to have similar associations of plaque and Intima-media Thickness (IMT) with age in males
however this relationship did not exist in females. 3DUS measurements of carotid atherosclerosis
can provide a more sensitive estimation of disease burden in vulnerable patient populations than
traditional measures.

Keywords: Atherosclerosis, Stroke, Age, Sex, Three-dimensional Ultrasound, Vessel Wall
Volume, Total Plaque Volume, Semi-automated, Validation
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Chapter 1: Introduction
1.1 Overview
Cardiovascular disease (CVD) is projected to be the number one cause of global mortality in 2020
with ischemic heart disease as the leading cause and cerebrovascular disease as the second leading
cause of mortality.1 Causes of ischemia stem from atherosclerotic disease of the vessels, a common
precursor in ischemic stroke and heart disease. In recent years, the mortality rate of CVD in
developed countries has stabilized due to management of modifiable risk factors.2 In low and
middle income countries however, cardiovascular disease mortality continues to rise due to
inadequate treatment and limited prevention of risk factors for CVD.

3, 4

Of these deaths, stroke

causes approximately 5.7 million deaths per year or 10% of all deaths.5 This number is expected to
rise to 7.8 million deaths worldwide by 2030.6 Ischemic strokes are the most common form
accounting for 87% of all strokes.2 In Canada, treatment of ischemic stroke costs over $50,000 per
year for each patient and 73% of those who experience stroke will access health care again within
the next 5 years.7, 8
Atherosclerosis is a disease of the arteries whereby circulating factors provoke an inflammatory
response that often leads to the formation of plaque. This disease not only plays a role in stroke but
also causes coronary events such as myocardial infarction. Large longitudinal observational studies
have identified modifiable risk factors for stroke such as hypertension, abdominal obesity, diet,
smoking and physical inactivity.9

Treatment and monitoring of atherosclerosis and its

manifestations depends on methods of plaque detection.

Effective strategies for reducing

cardiovascular disease require sensitive measurements that are safe, non-invasive assessment
techniques that can be widely adopted.
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Within the past 30 years imaging modalities such as ultrasound have been proven to be valuable in
characterizing atherosclerosis.10 Three-dimensional ultrasound (3DUS) imaging phenotypes have
been previously developed, however the understanding of their clinical meaning is unclear and
translation of these tools into clinical practice has been delayed. The first section of this thesis
focuses on establishing carotid ultrasound imaging phenotypes. The relationships between different
measurements of atherosclerosis are explored through comparison and are also related to age. The
second section describes the development of a semi-automated measurement which quantifies
carotid artery plaque volume. Semi-automated segmentation measurements such as this increase
the clinical potential of research tools.

1.2 Anatomy
Atherosclerosis is a progressive disease that commonly occurs in mid to large arteries of the
vasculature. The carotid arteries are of particular physiological importance as they supply the brain
(internal carotid artery (ICA)) and facial tissue (external carotid artery (ECA)) with oxygenated
blood. The ascending aorta is supplied with blood from the left ventricle of the heart. The left
common carotid artery branches off of the aortic arch and transports oxygenated blood to the brain
and face. The right common carotid artery stems from the brachiocephalic artery which also
branches from the aortic arch. Proximal to their origins each common carotid artery bifurcates into
the internal and external carotid arteries as shown in Figure 1-1.

3

Figure 1-1. Carotid Artery Anatomy. The common, internal and external carotid arteries and
structural layers of the artery. Arteries in the neck adapted from11 vessel composition adapted
from12.

The carotid arteries are composed of several adjacent layers each of which has unique structural
properties. The innermost layer of the artery is the intima. Endothelium lines the lumen-intima
boundary, a thin layer comprised of endothelial cells. These cells are connected by tight junctions,
which contribute to one of the functions of the endothelium; to act as a barrier to prevent
components of the blood diffusing out of the vessel lumen.13

Endothelial cells also secrete

important factors that help regulate adhesion of molecules that maintain the tone of the vessel
through vasoconstriction and dilation. The intima is also comprised of some smooth muscle cells,
collagen, proteoglycans and an elastic component. The internal elastic lamina separates the intima
from the adjacent media layer. The media is primarily comprised of smooth muscle cells however
it also contains collagen and elastic components. The surrounding adventitia is the outermost layer
of the artery consisting mostly of connective tissue and some smooth muscle cells and fibroblasts14.
The adventitia attaches the artery to surround tissue.

4

1.3 Risk Factors
Cholesterol levels have historically been used as a predictor of coronary heart disease15. Low
density lipoprotein (LDL) is responsible for the transport of cholesterol to cells. However in its
oxidized form it is toxic to the arterial wall and contributes to atherosclerosis and plaque
development16. Apolipoprotein B is the main protein found in LDL and is considered to be a better
predictor of ischemic events than cholesterol levels.17 Apolipoprotein B is found not only in LDL
but also intermediate density lipoprotein, very low density lipoprotein, and chylomicrons all of
which are considered to promote atherosclerosis.17
Longitudinal observations of cardiovascular outcomes have been important in identifying risk
factors for heart disease and stroke.

Cardiovascular risk scores have been generated from

observations in populations monitored over time. The Framingham Heart Study followed 2489
men and 2856 women over a period of 12 years to identify and categorize 10-year risk of heart
disease derived from a point system that uses age, LDL cholesterol levels, HDL cholesterol levels,
blood pressure, diabetes and smoking to calculate a risk score.15 Various risk score systems have
been created (SCORE, WHO/ISH, Reynolds Risk Score, QRISK, PROCAM, ASSIGN) which
identify ischemic heart disease risk factors that are also risk factors for stroke.18-24

Several

modifiable risk factors for stroke have been identified such as hypertension, smoking, abdominal
obesity, diet and physical inactivity.9
Hypertension or elevated blood pressure is defined as systolic blood pressure > 140 mmHg and
diastolic > 90 mmHg with increased systolic blood pressure hypertension more common.25 Risk of
developing hypertension increases with age with lifetime risk > 85% in women and > 80% in
men.26 Hypertension has been suggested to be the principal determinant of atherosclerosis.27
Detection and management of blood pressure is important in stroke prevention as a 20 mmHg
systolic or 10 mmHg diastolic increases mortality rates twofold.25
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Smoking and passive exposure to tobacco smoke measured in pack-years are contributors to
atherosclerosis disease of the arteries. The effects of smoking appear to be cumulative as there is
no association between smoking status and the progression of the disease.28 Smoking has been
shown to have effects on vasculature decreasing the ability of the vessel to stretch and thus
affecting blood vessel compliance which is defined as the change in volume divided by change in
pressure.12,

29

In addition to structural effects, smoking also causes changes in properties of the

blood. For example, smoking stimulates an inflammatory response in the arteries and increases
blood viscosity.30 Increased hematocrit and elevated levels of white blood cells and fibrinogen in
response to tobacco smoke could contribute to atherosclerosis.
The Northern Manhattan Stroke Study identified obesity as an independent risk factor for ischemic
stroke particularly among those < 65 years of age. Obesity was identified as a stronger predictor of
stroke than body mass index (BMI).31 It is hypothesized that adipose tissue secretes cytokines
which have similar effects on endothelial function as seen in diabetes.32 Katsiki et al. describe the
obesity-stroke paradox where following stroke, obese patients have a lower risk of mortality than
those with normal BMI.33 The advantageous effects of obesity following stroke remain unclear.
Diabetes is also a co morbidity associated with stroke increasing the risk of ischemic stroke due to
factors relating to insulin resistance.34 The processes that characterize this disease have significant
impacts on endothelial cells. Hyperglycemia, dyslipidemia and insulin resistance all contribute to
endothelial dysfunction. In the early stages of atherosclerosis, diabetes conditions lower levels of
nitric oxide which results in vasoconstriction, inflammation and thrombosis.35
Alcohol intake has been identified as a risk factor for stroke.36 The amount of alcohol consumption
has been linked to different outcomes. While there is uncertainty surrounding the effects of low to
moderate intake,37 heavy drinking or binge drinking (300 g/wk) has been shown to increase the risk
of stroke by a factor of four.38 Although hemorrhagic stroke is less common, studies have also
shown that heavy drinking has increased risk of stroke.39 Many studies have used self-reported
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alcohol consumption which often underestimates frequency of drinking alcohol while other
biomarkers such as serum gamma-glutamyl transferase may provide a more objective measure of
intake.40 In large amounts, alcohol raises blood pressure, has the potential to disrupt plaques and
can cause cardiomyopathy.36 There has been some evidence that indicates that moderate alcohol
intake can protect against ischemic stroke increasing high density lipoproteins (HDLs),
plasminogen activator, insulin sensitivity and decreasing lipoprotein (a), platelet aggregation and
fibrinogen.37, 41
Psychosocial factors have also been linked to stroke events. While a number of different factors
could potentially contribute, depression has been associated with stroke mortality. Over a 29 year
time period, depressive symptoms increase the risk of stroke mortality by 50%.42
Physical activity and diet have effects on insulin and lipid levels as well as endothelial function.
Exercise is hypothesized to lower lipids, improve insulin sensitivity, have anti-thrombotic effects
and prevent endothelial dysfunction through effects on inflammatory cytokines.43 Physical activity
also has hypotensive effects decreasing resistance of the arteries and promoting function of
endothelial cells.44 Diet also plays an important role in atherosclerosis as animal studies have
shown low-cholesterol diets can contribute to the stability of plaques.45
While all of the risk factors discussed here are modifiable, there are certain factors that increase
stroke risk which are predetermined. Age, sex, race and family history determine predisposition to
stroke.46, 47 Increased age is a central predictor of stroke risk. In fact, stroke risk doubles every
decade after the age of 55.48 Aging causes remodelling of the arteries such as fracturing of elastin,
increased collagen levels and calcification within the intima resulting in arterial stiffening leading to
reduced compliance49. Compliance is also affected by hormone levels as increases in compliance
have been shown in post-menopausal women on hormone replacement therapy.50
There are a number of emerging risk factors for vascular disease that may provide more accurate
prediction of stroke events. These biological factors include biomarkers of inflammation,
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thrombosis, platelet characteristics and activity, lipids and associated molecules as well as other
factors.51 C-reactive protein is an acute-phase protein produced by the liver in response to tissue
injury. Increases in levels of c-reactive protein are associated with coronary heart disease and
indicate the presence of inflammation, a component of arterial atherosclerotic disease.52 This acutephase protein is associated with obesity and diabetes and may up-regulate endothelial cell adhesion
and LDL oxidation by macrophages.53-55
Lipoprotein (a) (Lp(a)) is also associated with vascular disease. This biomarker is an indicator of
stroke and is associated with increased mortality.56,

57

Lipoprotein (a) resembles LDL and is

composed of a protein component (apo B100) covalently bonded to a glycoprotein (apolipoprotein
(a)).58 Circulating Lp (a) is thought to promote thrombosis as this molecule is similar in structure to
plasminogen and may inhibit its functions.59 It also promotes atherosclerosis as levels of lipoprotein
(a) rise in response to inflammation increasing smooth muscle cell migration and transport of
cholesterol to the site of plaque development.60 Levels of serum Lp (a) have been shown to be
genetically determined with increased levels associated with atherosclerosis.57
Fibrinogen is another emerging biomarker that has received attention in identifying precursors of
plaque development. Fibrinogen is a glycoprotein which is converted by thrombin to fibrin a
clotting factor that functions in end stages of coagulation.61 Thus, fibrinogen has potential effects
on thrombosis. Elevated levels of this glycoprotein have been correlated with plaque and intimamedia thickening.62
Homocysteine is an amino acid involved in methionine metabolism which has been shown to be
elevated by approximately 20% in those who experience stroke.63 Homocysteine is thought to
promote vascular disease through multiple mechanisms.
thrombosis by increasing coagulation.64

One such mechanism is promoting

Additionally, homocysteine acts as a catalyst in the

production of hydrogen peroxide causing damage to endothelial cells.65

Individuals with
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homocystinuria, an autosomal recessive disease, are at an increased risk of developing accelerated
atherosclerosis in addition to other complications.64

1.4 Carotid Atherosclerosis and Classification of Plaque
In the past, theories that describe the process of atherosclerosis have focused on accumulation of
cholesterol, however, inflammation has been identified as an essential component in the
pathophysiology of this disease.53 Monocyte chemotaxis is an essential step in the initiation of
plaque development. The probability of leukocyte adhesion is increased in areas of nonlaminar
flow where turbulence creates a pooling affect at areas of low shear stress and increases the
potential for interaction between circulating molecules and endothelial cells.

Oxidized LDL

particles within the intima provoke the recruitment of monocytes and stimulate changes in the
endothelium. Leukocyte migration into the intima is caused by increased adhesion and permeability
of the endothelium due to an increase in the levels of receptors expressed on these cells66. Once
monocytes have penetrated the endothelial barrier, they are transformed into macrophages which
phagocytose oxidized LDL particles.

Oxidized LDL particles increase activity of matrix

metalloproteinases, smooth muscle cell apoptosis and impair nitric oxide production16.
Plaques have been categorized by the American Heart Association into six stages of development.67,
68

In the initial stages of early plaques, macrophages accumulate cholesterol forming foam cells.

Foam cells are only visible under microscope however contribute to intimal thickening and are
classified as Type I plaques. Multiple foam cells produce spots or streaks along the endothelium.
The increase in foam cells is due to the auto-amplification phenomenon where foam cells release
cytokines which stimulate the immune response.66

Chemotaxis of monocytes leads to the

production of more foam cells and subsequently more chemokines. Layering of foam cells in
combination with mast cells, T lymphocytes and smooth muscle cells characterize type II lesions.
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A preatheroma or intermediate plaque is classified at a type III lesion. Separate lipid pools are
formed due to accumulation of extracellular lipids beneath layers of foam cells. Lipid pools lead to
the reorganization of smooth muscle cells in the intima causing thickening of this layer.
Disorganization of the intimal layer due to additive effects of multiple lipid pools results in the
formation of a lipid core. The lipid core is the distinguishable feature of Type IV (atheroma)
lesions which along with type III lesions could lead to erosion and formation of a thrombus. Foam
cells in combination with mast cells, T lymphocytes and smooth muscle cells are found in between
the endothelial layer and the lipid pool which is surrounded by vasa vasorum originating from the
adventitia layer.

Figure 1-2. Stable atheroma indicating direction of plaque progression. Lumen occlusion is
absent in early stages of plaque formation as artery compensates to maintain normal blood flow
(light blue). In later stages of plaque development stenosis occurs (dark blue). Adapted from69.
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Glagov describes the progression of plaque in relation to lumen area which is indicated in Figure 12.

As the intima layers thicken the vessel compensates, growing outward and preventing

obstruction of flow. The artery expands until the plaque has occupied 40% of the internal elastic
lamina at which point the lesions begins to encroach into the lumen. Compensatory enlargement of
the vessel preserves unobstructed flow in the lumen until late stages of atherosclerosis.70
Fibroatheroma or Type Va lesions have fibrous cap development around the lipid core composed of
smooth muscles cells and collagen. The fibrous cap is developed to separate the lipid core from the
arterial lumen. Type Vb lesions are characterized by calcification from smooth muscle cell secreted
osteopontin. Type Vc lesions are typically termed fibrous plaque where lipid levels decline and are
replaced with connective tissue.
The final lesion type classifies complicated lesions often associated with cerebrovascular events.
While type VIa lesions include plaques with ulcerations and fissures, type VIb refers to lesions with
hemorrhage of vasa vasorum within the plaque and type VIc are lesions involved in thrombosis due
to external mechanical forces from blood flow.71

1.5 Treatment of Atherosclerosis
Lifestyle factors such as physical activity and exercise can be altered to prevent plaque formation
and slow arterial disease.72 Deviation from atherogenic diets to diets which reduce cholesterol
levels decreases intimal area by approximately 60% and reduces foam cells and inflammation of the
artery.73 Dietary intervention slows progression of vascular disease and promotes regression of
plaque, an outcome which can be improved when combined with drug therapy.74
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1.5.1 Drug therapy
When primary interventions alone are no longer sufficient, therapies which target specific risk
factors can be effective in reducing cardiovascular event risk and disease progression. LDL was
previously mentioned as a risk factor for stroke and is an important component in the formation of
plaque. Serum LDL levels can be lowered with statin therapy, a group of HMG-CoA reductase
inhibitors that lower the production of cholesterol in the liver.75 HMG-CoA reductase is an enzyme
involved in the rate-limiting step of cholesterol synthesis.76 Inhibition of its activity leads to
reduced levels of LDL cholesterol formed and increased LDL receptors.75 In the Cholesterol and
Recurrent events trial (CARE), pravastatin was shown to reduce stroke by 32% following
myocardial infarction.77 Atorvastatin treatment of 80 mg per day reduced risk of stroke by 33%
with the greatest benefits seen in subjects with carotid stenosis.78 Other statins such as simvastatin
have shown to reduce mortality79 and have a similar reduction in ischemic stroke of approximately
30%.80
Management of co-morbidities is also an important factor in treatment of atherosclerosis. Several
mechanisms have been identified to lower blood pressure.12 ACE inhibitors such as ramapril
prevent the conversion of angiotensinogen to angiotensin II inhibiting its actions. Actions of
Angiotensin II lead to increased blood pressure and include vasoconstriction, increased sympathetic
output to the cardiovascular system, increased vasopressin, elevated levels of aldosterone and thirst.
A meta-analysis of antihypertensive therapies estimated from placebo-controlled trials that ACE
inhibitors reduced the risk of cardiovascular events by 20-30%.81 Beta blockers and diuretics are
also used to treat hypertension and do not differ significantly in treatment effects in relation to
morbidity and mortality.82
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1.5.2 Surgical Intervention
Surgical intervention in late stage atherosclerosis has potential benefits in reducing stroke risk. The
North American Symptomatic Carotid Endarterectomy Trial (NASCET) identified significant
benefits in carotid endarterectomy procedures for symptomatic subjects with significant stenosis
(>70%) and in those with moderate stenosis (50-69%) benefits were also observed. Other large
scale surgical trials including the European Carotid Surgery Trial have reported similar benefits for
endarterectomy in symptomatic patients with severe stenosis.83,

84

Similar studies evaluating the

benefits of carotid endarterectomy (stenosis >60%) in asymptomatic subjects have shown a 66%
five-year stroke risk reduction in men post-endarterectomy compared to 17% in women.85
Another surgical treatment which restores plaque-impeded blood flow is carotid angioplasty and
stenting. A wire is inserted through either the femoral or carotid artery and guided to the site of the
lesion where a balloon catheter expands the artery for stent placement. Stenting has been shown to
produce similar outcomes in mortality and stroke and may provide an advantage over
endarterectomy as shorter hospitalization have been reported.86 Neurological complications such as
disruption of plaque and emboli limit this intervention.87 While surgical interventions provide
treatment for advanced lesions, primary interventions which aim to prevent plaque formation are
the most effective in reducing stroke mortality.

1.6 Imaging Carotid Arteries
1.6.1 X-Ray Based Methods
Angiography is an imaging technique that uses contrast agents and x-ray to assess structural
changes in coronary or carotid artery lumen. X-ray angiography is useful in detecting calcification
within plaque and narrowing of the artery due to thickening of the fibrous cap and associated
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inflammatory activity. Extent of luminal stenosis is important in determining whether surgical
intervention is necessary. This method is an important tool for late stage lesions however it does
not provide useful information of early stage plaques.

This imaging modality is limited in

accurately detecting reduction in luminal area as atherosclerosis can be diffuse and comparisons to
neighboring normal segments may not be representative due to the presence of plaque in these
regions.88 While x-ray angiography provides information pertaining to stenosis of the artery,
stenosis is not the exclusive cause of ischemic symptoms. Symptoms can be caused by ulcerated
lesions, while additionally significant stenosis can result in asymptomatic patients.85, 89

1.6.2 Magnetic Resonance Imaging (MRI) Methods
Magnetic Resonance imaging (MRI) utilizes molecular spin properties of protons within the body,
an external magnetic field generated by a powerful magnet and radiofrequency pulses to generate
an image. MRI can provide pertinent information in describing atherosclerosis burden such as
plaque composition and luminal stenosis which has been validated with histopathology.90 While
bright-blood pulse sequences suppress tissue surrounding blood flow enabling identification of
luminal stenosis, this method often produces signal void due to abnormal flow. Black-blood
imaging techniques are preferable as suppression of blood flow signal allows for visualization of
arterial wall structures.91

Using various contrast agents such as gadolinium and ultrasmall

superparamagnetic particles of iron oxide (USPIO) is important in increasing image resolution and
distinguishing between plaque components.92-95 MRI is limited in that it is an expensive imaging
modality that is also time intensive.

However, characterization of plaque and its surface

irregularities from MRI techniques has been shown to correlate well with ischemic symptoms.96
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1.6.3 Ultrasound Imaging Methods
Ultrasound imaging is a safe, noninvasive technique for characterization of vascular disease. A
piezoelectric transducer generates mechanical waves that penetrate tissue. As the wave travels
through various structural components it is attenuated and reflected back to the probe where
variations in reflected acoustic waves are detected and transformed into an image. Quantifying
atherosclerosis using ultrasound imaging is highly dependent on image acquisition and optimization
settings selected by the sonographer.

1.6.3.1 Intravascular Ultrasound (IVUS)
Intravascular ultrasound (IVUS) provides information of plaque size and morphology and has been
validated with histopathology post-mortem.97,

98

A catheter with a small ultrasound transducer

rotates within the artery and is advanced or retracted while ultrasound images of the surrounding
tissue are recorded for analysis.99 High frequency probes produce high resolution images of vessel
wall layers and plaque composition. Lipid deposits present as hypoechoic while fibrous tissue and
collagen produce a bright signal.100

Table 1-1 compares resolution, radiation dose, and

invasiveness for IVUS and other imaging modalities discussed in this chapter. Lumen area is
estimated using planimetry by outlining the lumen-intima boundary,101 however the thickness of the
intima and medial layers is at times hard to distinguish.98 While this modality has numerous
advantages over x-ray angiography, this method is limited by certain factors. IVUS is an invasive
procedure with the potential to disrupt plaque and cause thrombosis. Furthermore although it can
distinguish plaque and calcification, it is limited in imaging of thrombi, soft plaque and hard
plaque.99
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Table 1-1. Invasiveness, Radiation Dose and Resolution of Atherosclerosis Imaging Methods.
Adapted from Tardif et al. 2011.102
Imaging Modality
Coronary angiography
IVUS
Carotid Ultrasound

Invasive
+
+, catheter
-

Radiation
+
-

Resolution
0.4 mm
0.08-0.10 mm
0.15 mm

1.6.3.2 Doppler Ultrasound
Doppler ultrasound has been recognized by the Society of Radiologists in Ultrasound as an
important tool in measurement of carotid artery imaging and is suggested for characterizing internal
carotid artery stensosis.103 The Doppler Effect is described as the observed change in frequency of
a longitudinal wave due to motion between an observer and the source of the pressure wave.104
Blood flow velocity is determined through acquisition of reflected ultrasound frequencies which
generate a Doppler shift that can be displayed visually with Colour Doppler.
This tool has the ability to identify lesions which are associated with altered flow patterns as
determined by laser velocimetry.105 Doppler ultrasonography is also useful in estimating aortic
compliance non-invasively using pulse wave velocity which is inversely related to compliance.
Risk factors for CVD and cardiovascular events are associated with stiffer aortas when compared to
healthy controls.106 While Doppler provides a safe and inexpensive assessment of patients for
therapy or endarterectomy, endothelial dysfunction indicated by abnormal acetylcholine response
has been shown in patients with nonsignificant Doppler findings for vascular disease.107 Early stage
evaluation of atherosclerosis may be inadequate and made worse by variation between operators.

1.6.3.3 Carotid B-mode Ultrasound
B-mode or “brightness” mode ultrasound uses a transducer, which is placed on the surface of the
skin where it generates ultrasonic longitudinal waves that penetrate tissue. The pulse generated is
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reflected differently depending on composition of various structures which creates echoes of
varying intensity which travel back to the trasnducer. This pulse-echo method is used to map out
underlying structures with more reflective materials appearing brighter. B-mode ultrasound is a
well-established imaging modality and thus is commonly used in the clinical realm. Ultrasound
imaging phenotypes have been developed to objectively measure atherosclerosis from B-mode
images.108
The intima-media thickness (IMT) is a measurement of the intimal and medial layers in the far wall
of the artery for a 10 mm wall segment of the common carotid artery (CCA), carotid bulb or ICA.109
Intima-media thickness as illustrated in Figure 1-3 has been identified as an endpoint for clinical
studies and has been correlated with stroke and myocardial infarction.110 Intima-media thickness
has shown to be significantly but modestly positively associated with cardiovascular risk factors
such as systolic blood pressure, LDL cholesterol, triglycerides, blood glucose and inversely
correlated with HDL cholesterol.111, 112

Figure 1-3. B-mode ultrasound intima-media thickness. IMT measurement in red generate from
intima-lumen and media-adventitia interfaces for 10mm of the common carotid artery.
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IMT has been suggested to represent biological processes other than plaque development as plaque
grows 2-4 times faster in length than in thickness.113 Plaque is also a disease of the intima. Since
the intima is quite thin, the IMT measurement is mostly reflective of medial thickening.114
Total Plaque Area (TPA) is a two-dimensional measurement of carotid plaque area using B-mode
ultrasound. In a longitudinal view, cross-sectional areas of plaque are measured in the internal,
external and common carotid arteries and all areas are summed. TPA has been shown to be a risk
factor for clinical cardiovascular symptoms.115

This phenotype is also useful in evaluating

interventions as folic acid, Vitamin B6 and Vitamin B12 treatment have been shown to reduce TPA
in patients with elevated homocysteine at increased risk for atherosclerosis.116 Significant change
(regression or progression) in total plaque area for longitudinal comparisons is defined as ≥ 0.05
cm2 while plaque is defined as intima-media thickening > 1mm.115, 117 Longitudinal comparisons of
TPA may however be limited in that cross-sectional areas measured at different time points may be
taken at different locations within the plaque. Cross-sectional areas are identified by the observer
and thus are subjective. Additionally, TPA provides information of plaque length and residence
along the artery however this measurement does not accurately estimate the shape or volume of
plaque.

1.6.3.4 Three-Dimensional Ultrasound (3DUS)
Three-dimensional ultrasound (3DUS) systems construct 3D ultrasound images using traditional 1dimensional transducers. Several parallel 2D images are collected and digitized within a 3D
volume to be reconstructed into a 3D image. Scanning methods include mechanical scanning, freehand or 2D array. Optimal scanning utilizes mechanical acquisition which rapidly acquires 2D
frames and prevents motion artefacts. Additionally, parallel 2D images are of the same orientation
and are equal spaced, which allows for simple linear interpolation of pixels to create 3D voxels.118
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1.6.4 Emerging 3DUS Imaging Phenotypes
1.6.4.1 3DUS Carotid Vessel Wall Volume
In contrast to IMT measurements that are commonly generated at the carotid bulb and do not
include atherosclerotic plaque lesions, 3DUS vessel wall volume (VWV) provides a 3D
circumferential wall and plaque volume measurement that has been shown to be sensitive to
longitudinal changes

119-121

even in subjects without echogenic plaque or significant changes in

intima-media thickness. 122, 123 The VWV is shown in Figure 1-4.

Figure 1-4. Three-dimensional ultrasound (3DUS) vessel wall volume (VWV). Cross-sectional
areas in the axial view are segmented and multiplied by the interslice distance (1 mm) to calculate a
volume. Lumen-intima boundary (blue) is subtracted from media-adventitia boundary (red) to
calculate the wall volume of the common carotid artery. The volume of the internal common
carotid (proximal to bifurcation, BF) is calculated as the difference in cross-sectional areas of the
media-adventitia boundary (yellow) and the lumen-intima boundary (green). The internal and
common carotid artery volumes are summed to generate the total VWV.
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The high reproducibility of the vessel wall volume measurement124 has been demonstrated with the
intra-observer coefficient of variation of 6.5% when compared to 4.7% for IMT. The inter-scan
coefficient of variation for VWV has been shown to be 13.5% compared to 8.9% for IMT.125
Additionally, intrascan variability of VWV has also been reported with a coefficient of variation of
4.6% and an intraclass correlation coefficient of 0.95. The interscan reproducibility of VWV was
demonstrated with a coefficient of variation of 5.7% and an interclass correlation coefficient of
0.85.124 Egger et al. have also shown in a study of five subjects with carotid stenosis, no significant
difference between subjects at scan and rescan two weeks later.126 Additionally, Krasinski et al.
analyzed subjects receiving atorvastatin treatment at baseline and three months later with
comparison to a control group. Those receiving treatment showed a significant change between
scan and rescan as VWV increased by 70 ± 140 mm3 (+4.9 ± 10.3%) in the placebo group and
decreased by 30 ± 110 mm3 (-1.4 ± 7.7%) in the atorvastatin group (p < 0.05).127 VWV can be used
to generate carotid artery thickness maps indicating regions of atherosclerosis along the carotid
artery.126

1.6.4.2 3DUS Carotid Total Plaque Volume
Total Plaque Volume (TPV) is a 3D ultrasound measurement that estimates the total amount of
plaque within the carotid arteries. Areas of hyperechoic signal are measured indicating the presence
of calcification. Currently, this method uses manual planimetry to outline plaque areas slice by
slice. The interslice distance between two slices is multiplied by the average area of those slices to
generate an incremental volume. All incremental volumes are added to generate the total plaque
volume. This method is time consuming taking upwards of 7 minutes for the generation of one
plaque volume as the observer may have to manually trace plaque areas for 30 slices per plaque.128
Although time consuming, the accuracy of this measurement has been demonstrated using agar test
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phantoms ranging from approximately 70 mm3 to 285 mm3 with a mean accuracy of 3.1 +- 0.9%.129
Landry et al have identified a decreasing trend in the coefficient of variation for increasing plaque
volume using the manual planimetry method.130, 131

Figure 1-5. Three-dimensional ultrasound (3DUS) total plaque volume (TPV). Cross-sectional
areas in the axial view are segmented and multiplied by the interslice distance (1 mm) to calculate a
volume.

1.7 Research Hypothesis and Objectives
We hypothesize that three-dimensional ultrasound measurements of carotid atherosclerosis can
provide a more sensitive estimation of disease burden in vulnerable patient populations than
traditional measures. Two primary objectives of this thesis are to 1) characterize the relationship of
three-dimensional ultrasound vessel wall volume with age and 2) develop a novel semi-automated
approach for the estimation of total carotid plaque volume. The objectives described here were
developed to provide rapid estimation of atherosclerotic disease and improve our understanding of
interpreting 3DUS measurements as they relate to cerebrovascular event risk.
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In Chapter 2, we investigate the relationship between ultrasound imaging phenotypes and age.
Intima-media thickness, vessel wall volume and total plaque volume measurements were correlated
in subjects with moderate disease. We hypothesize that age will correlate with 3D ultrasound
phenotypes such as vessel wall volume and total plaque volume with similar strength of association
established previously between age and traditional two dimensional ultrasound measurements such
as the intima-media thickness.
In Chapter 3, we investigate total plaque volume as a potential clinical tool for the sonographer to
utilize at the bedside. The semi-automation of this measurement allows for rapid estimation of
plaque burden post scan.

We hypothesize that the semi-automated total plaque volume

measurements will yield similar intraobserver and interobserver variability in comparison to the
manual segmentation method.

Comparisons of semi-automated measurements to a manual

reference standard are described to demonstrate accuracy of the novel approach.
The current limitations of three-dimensional ultrasound measurements are explored in Chapter 4
and recommendations are made for future work in establishing these phenotypes as clinical tools.
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Chapter 2: The Relationship of of Carotid ThreeDimensional Ultrasound Vessel Wall Volume with Age
and Sex: Comparison to Carotid Intima-media
Thickness
2.1 Introduction
Ultrasound imaging of the carotid arteries is a relatively low-cost and direct method for generating
regional measurements of arterial wall thickness and plaque

1-3

.

Such ultrasound (US)

measurements of carotid atherosclerosis include the well-established one-dimensional measurement
of arterial wall intima-media thickness (IMT) measured using B-mode US and three-dimensional
(3D) US measurements including total plaque volume (TPV) 4-10 and vessel wall volume (VWV) 6,
11-19

. IMT measurements of the common carotid artery are associated with ischemic atherosclerotic

events 20 and are predictive of ischemic stroke 21, 22. Previous studies have established a relationship
between intima-media thickness and age

23-25

and this relationship was stronger at the carotid

bifurcation 24. Intima-media thickness is typically lower in women and surprisingly, in both sexes,
carotid IMT is greater in the left carotid artery compared to the right 26-28.
Recently, the Tromsø study suggested that both age and sex were correlated with carotid
atherosclerotic plaque and its morphology and that the presence of carotid plaque was a direct
determinant of cardiovascular events in men

29

. These results underscore the need for a better

understanding of the relationships between US measurements, age and sex when interpreting
carotid US results in clinical studies. While currently it is well-established in healthy adults that
there is a positive relationship between carotid artery IMT and age/sex

24, 30, 31

, there have been no

3DUS studies that interrogate these relationships. In previous studies we showed the increased
sensitivity of 3DUS VWV compared to the gold standard IMT15,16. However, while we have
measured 3DUS and B-mode US carotid atherosclerosis measurements in many subjects, we have
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never evaluated the relationships of these measurements to age or sex. We hypothesized that age
and sex were also significant determinants of 3DUS vessel wall volume even in subjects with
underlying atherosclerosis and therefore in this study we evaluated these relationships in a relatively
large group of patients with diabetes, rheumatoid arthritis or obesity, all of which have been shown
to share carotid atherosclerosis as a comorbidity.

2.2 Methods
2.2.1 Study Subjects and Design
Four different types of study subjects were evaluated and written informed consent was provided
according to a study protocol approved by a local research ethics board. Subjects with diabetic
nephropathy were recruited from nephrology and diabetes clinics at the London Health Sciences
Centre (London, Canada) and required a diagnosis of type I or type II diabetes mellitus and a
clinical or histologic diagnosis of diabetic nephropathy, and at least 300 mg/d of urinary albumin
excretion or 500 mg/d of protein excretion.

Subjects were excluded if they were currently

undergoing dialysis or had a calculated creatinine clearance lower than 30 mL/min or an
expectation of mortality or complications during the course of the study. Subjects with mild obesity
aged 40 to 65 years with body mass index (BMI) ≥ 27 kg/m2 were evaluated with or without type II
diabetes mellitus or coronary heart disease 16. Post-kidney transplant patients were evaluated with
end-stage renal disease that required a primary or secondary renal allograft, a history of diabetes,
hypertension, ischemic heart disease and previously reported cardiovascular events. Subjects with
mild to moderate rheumatoid arthritis were also evaluated with symptomatic joint disease greater
than three months, swollen joint count ≥ 6 and tender joint count ≥ 8.
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2.2.2 Image Acquisition Parameters
High-resolution B-mode images were acquired with an optimized US system for carotid imaging
(ATL HDI 5000; Philips, Bothel, WA, USA) with a 50 mm L12–5 MHz transducer with a central
frequency of 8.5 MHz (Philips).

Ultrasound imaging parameters such as gain, time-depth

compensation and focal points were optimized for each subject by the sonographer, taking into
consideration the neck size, carotid anatomy and tissue depth penetration required. 3DUS images
were acquired by freehand scanning along the neck for a distance of approximately 5 cm from
clavicle to jaw. Probe orientation and position were tracked with a magnetic tracking system, and
2-dimensional images were reconstructed into a 3D volume as previously described 32-34.

2.2.3 IMT Segmentation
For obese subjects, intima-media thickness was measured from longitudinal image planes extracted
from 3DUS images as previously described

16

. For diabetic, post-transplant and arthritis subjects,

IMT was measured using B-mode ultrasound imaging from longitudinal frames that were recorded
on VHS tape or digitally recorded on DVD. All IMT measurements were generated using Prowin
24.0 (Medical Technologies International Inc, Palm Desert, CA, USA) for segmentation as
previously described

35, 36

. To briefly summarize, after calibration, measurements were generated

from a 10mm segment of the far wall of the common carotid artery, approximately 5 mm distal to
the carotid bulb. A different segment was selected for measurement if plaque was identified in that
location (defined as focal thickening > 1 mm) or if that segment was not included in the 3DUS
volume. Between 6 and 12 points were marked along the media-adventitia and the intima-lumen
boundary with a mouse-driven cursor. For the measurement of intima-media thickness, the distance
between the curves defined by the points was generated. Measurements were repeated three times
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per image side (left (L) and right (R)), and the median value for the L and R common carotid was
used to generate mean IMT for each subject.

2.2.4 3DUS Total Plaque Volume Segmentation
Total plaque volume (TPV) was measured using a semi-automated approach as described elsewhere
37

.

Briefly, in the longitudinal 3DUS view, the first of three segmentation boundaries was

segmented at the approximate centre of the plaque. The first segmentation boundary was used to
identify the end points of the plaque in the longitudinal view. In the axial view the observer
segmented an additional two boundaries which were used to estimate plaque morphology. The end
points were then interpolated to anchor points on the axial segmented boundaries to generate
several surface areas used to compute the enclosed volume.

The volume for all individual

atherosclerotic plaques was summed for each of the L and R carotids and the mean of L and R was
used to generate mean TPV for each subject.

2.2.5 3DUS VWV Segmentation
Five observers blinded to subject identity and clinical parameters analyzed all images and
performed 3DUS vessel wall volume manual
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or semi-automated segmentation 19. All observers

were trained and deemed to be functionally equivalent following a variability trial prior to analysis
of subject data. Four observers manually segmented VWV for diabetic, rheumatoid arthritis and
obese subjects, while a different single observer performed semi-automated segmentation

19

of

VWV for post-transplant subjects. While the interobserver variability of this algorithm has not been
studied, only one observer used the algorithm to generate VWV measurements in one of the
population groups. However, Ukwatta et al. have shown, using the same observer, that the
intraobserver variability of the semi-automated measurement was low at 5.1% compared to 3.9%
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with the manual measurement (not statistically significantly different) and the accuracy of the
measurement was quite high, yielding a dice coefficient of 95.4% ± 1.6% for the media-adventitia
boundary and 93.1% ± 3.1% for the lumen-intima boundary. Briefly, lumen-intima and mediaadventitia boundaries of the carotid artery were segmented and the area enclosed by each
segmented boundary was multiplied by the interslice distance, and all areas were summed to obtain
the final volume of the lumen and vessel wall. 3DUS VWV was generated as the difference
between the volume enclosed by the arterial wall and the volume of the lumen. For each subject, L
and R carotid vessel wall volume was averaged to generate a mean VWV.

2.2.6 Statistical Analysis
Statistical analyses were performed using IBM SPSS Statistics v. 19 (SPSS Inc, Chicago, Ill, USA).
The relationship between ultrasound measurements, age and sex was reported with Pearson’s r
statistic.

Linear regression was performed with GraphPad Prism version 4.01 for Windows

(GraphPad Software, La Jolla, CA, USA). Fisher Z transformations were applied to Pearson rvalues to compare correlations. One-way analysis of variance (ANOVA) was used to compare
mean values between subject groups. In all statistical analyses, results were considered significant
when the probability of making a Type I error was less than 5% (p < 0.05).

2.3 Results
2.3.1 Subject Characteristics
Subjects scanned were included in analysis if age and gender were recorded or could be obtained
from patients who were not lost to follow-up and images were of sufficient quality for the
measurement of IMT, TPV and VWV. For the obese subjects, of 175 patients scanned, 35 were
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excluded due to poor image quality, for diabetics, 12 of 77 scanned were excluded due to poor
image quality, for the post-transplant subjects, age was not recorded for 8 patients and they were
unfortunately lost to follow-up and hence no date of birth could be recorded; for RA subjects, 6
subjects did not have suitable image quality for analysis.

Table 2-1. Study Subject Demographics and Imaging measurements.
All
316

All
Males
236

All
Females
80

Obese
140

Diabetic
65

Posttransplant
83

Rheumatoid
Arthritis
28

55 (9)

55 (9)

57 (9)

51(6)

60 (11)

57 (10)

59 (10)

236 (75)

--

--

123 (88)

47 (72)

62 (75)

4 (14)

0.87(0.23)

0.90 (0.24)

0.76(0.17)

0.94 (0.26)

0.87 (0.23)

0.78 (0.17)

0.75 (0.13)

486 (144)

514 (141)

403 (120)

471 (128)

560 (144)

495 (144)

362 (121)

n
Age yr
Mean (SD)
Male Sex
n (%)
IMT mm
Mean (SD)
3

VWV mm
Mean (SD)

Subject demographics are provided in Table 2-1 for 316 subjects evaluated (mean age 55 ± 9 years,
75% male) as well as subjects by sex and subgroup: diabetic nephropathy (n=65), obesity (n=140),
renal transplant (n=83) and rheumatoid arthritis (n=28). Subjects from each patient group were
excluded if age, or intima-media thickness and vessel wall volume measurements were not
obtainable. Figure 2-1 shows the frequency distribution for variables evaluated in primary
comparisons.
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Figure 2-1. Frequency distribution of age, intima-media thickness and vessel wall volume by
sex.

2.3.2 Imaging Measurements
Figure 2-2 shows carotid ultrasound images for a younger male (40 yr) and an older male (70 yr)
subject. In Table 2-1, mean carotid intima-media thickness and vessel wall volume are provided for
all subjects.
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Figure 2-2. Representative imaging and carotid ultrasound measurements at different ages.
Intima-media Thickness is shown on the left and Vessel Wall Volume on the right for a young male
(40yrs) and an older male (70yrs). The red line in Intima-media Thickness measurement images
represents 10 mm. In Vessel Wall Volume measurements the red represent a cross-section of
contours that outline lumen-intima boundaries in the common carotid artery while blue contours
show media-adventitia boundary. The yellow lines represent contours that identify the lumenintima boundary in the internal carotid artery and the green represents contours that show the
media-adventitia boundary of the internal carotid artery. The interslice distance between contours is
1 mm.

A one way ANOVA was used to determine statistical significance for differences in age, IMT and
VWV for each subject group as well as males and females. All comparisons are summarized in
Figure 2-3. As previously described, mean IMT and VWV were significantly higher in males.
Mean age for obese subjects (51 ± 6 yrs) was significantly lower than in post-transplant (57 ± 10
yrs), diabetic (60 ± 11 yrs) and rheumatoid arthritis subjects (59 ± 10 yrs). Mean IMT for obese
subjects (0.94 ± 0.26 mm) was significantly higher than post-transplant (0.78 ± 0.17 mm) and
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rheumatoid arthritis subjects (0.75 ± 0.13 mm). Mean VWV in diabetics (560 ± 144 mm3) was
higher than in obese (471 ± 128 mm3), post-transplant (495 ± 144 mm3) and rheumatoid arthritis
subjects (362 ± 121 mm3).

Figure 2-3. Mean values for age, IMT and VWV by
subject group. Mean age (top), intima-media thickness
(middle) and vessel wall volume (bottom) are plotted for
all males, all females, post-transplant (PT), obese (OB),
diabetic (DB) and rheumatoid arthritis (RA) subject
groups. Mean values were compared with a one-way
ANOVA and statistically significant differences are
denoted by * (p< 0.05).

2.3.3 Relationship of IMT and VWV with Age and Sex
In Figure 2-4, the significant relationships are shown for intima-media thickness (r = 0.18, p =
0.001) and vessel-wall volume (r = 0.24, p < 0.01) with age. In males alone, IMT (r = 0.19, p =
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0.003) was also significantly correlated with age as was VWV (r = 0.34, p < 0.0001). In females,
IMT and age were significantly correlated (r = 0.30, p = 0.007), but VWV and age were not (r =
0.10, p = 0.4). In addition, there was no significant relationship (r = 0.15, p = 0.186) between age
and TPV in females.

Figure 2-4. Relationship between 3D ultrasound measurements of carotid atherosclerosis and
age. Intima-media Thickness and age (left) for obese, diabetic, transplant and arthritis populations
grouped and Vessel Wall Volume and age comparisons (right). Relationships also presented by sex
(middle and bottom).
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In Table 2-2, the Pearson r values for IMT and VWV and age are provided. The transformed Fisher
Z values were not significantly different indicating that the relationships between IMT and VWV
with age were not different.

Table 2-2. Pearson -Product-Moment correlations between IMT, VWV and age.
All
Male
Female
IMT mm
r (p-value) 0.18 (0.0012) 0.19 (0.0028) 0.30 (0.0071)
R2 0.03(0.0012) 0.04 (0.0028) 0.09 (0.0071)
VWV mm3
r (p-value)
R2
TPV mm3
r (p-value)
R2

0.24 (0.0001)
0.06 (0.0001)

0.34 (0.0001)
0.12 (0.0001)

0.10 (0.37)
0.01 (0.37)

ND

ND

0.15 (0.19)
0.02 (0.19)

The results of simple linear regressions are provided in Figure 2-4 and these were used to determine
the change over time (slope) for IMT and VWV. In all subjects, mean IMT increased by 0.005
mm/yr (p = 0.001), while VWV increased 4 mm3/yr (p < 0.01). In males, these values were similar
(IMT = 0.005 mm/yr (p = 0.003); VWV=5 mm3/yr (p < 0.0001)). In females, IMT increased 0.006
mm/yr (p = 0.007) and there was no relationship between age and VWV in females.
The relationships between intima-media thickness, vessel wall volume and total plaque volume are
shown in Figure 2-5. For males and females together (Figure 2-5, top L panel), the association
between IMT and VWV was significant (r = 0.55, p <0.0001), and in females alone (Figure 2-5,
bottom left) there was also a significant and positive correlation between IMT and VWV (r = 0.37,
p = 0.001). However, while in females VWV and TPV showed a significant relationship (r = 0.36,
p = 0.001) (top right panel Figure 2-5), there was no significant relationship between IMT and TPV
(r = 0.11, p = 0.34) (bottom right).
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Figure 2-5. Correlations between ultrasound measurements. Comparisons between Intimamedia Thickness and Vessel Wall Volume (left) are shown for all subjects (top-left) and female
subjects only (bottom-left). Correlations between Intima-media Thickness, Vessel Wall Volume
and Total Plaque Volume in females are shown (right).

2.4 Discussion
We made a number of observations in a relatively large group of subjects with a variety of diseases
as follows: 1) in all subjects, IMT correlated with VWV, and in females alone, VWV correlated
with TPV, but TPV did not significantly correlate with IMT, 2) in all subjects and in males
evaluated alone, IMT and 3DUS VWV were significantly associated with age, 3) in females alone,
IMT was positively and significantly correlated with age, but 3DUS VWV and TPV were not. It
has been well established for the ultrasound measurement of intima-media thickness that there is a

44
positive relationship with age. In other words, carotid IMT naturally increases over time by
fractions of a mm even in subjects without underlying disease or atherosclerosis. In subjects
without atherosclerotic plaque, 3DUS vessel wall volume is essentially a 3D IMT measurement and
in those subjects with plaque, 3DUS VWV consists of both atherosclerotic plaque and arterial wall
intima-media layers. We hypothesized that VWV and IMT would share a similar relationship with
age and sex and therefore in this study we explored the relationship between 3DUS carotid
atherosclerosis VWV with age and sex.
First, in all subjects we were not surprised to observe that intima-media thickness correlated with
vessel wall volume, and in females alone, VWV correlated with total plaque volume, but TPV did
not significantly correlate with IMT. While intima-media thickness has been used as a clinical
endpoint for longitudinal studies, the absence of a relationship between TPV and IMT suggests that
IMT does not provide a good estimate of the presence of plaque. In this regard, vessel wall volume
may be of more value as it is a comprehensive measurement that includes a cross-sectional IMT of
common carotid and internal carotid arteries with plaque volumes. Polak et al. have identified that
while intima-media thickness of the CCA and intima-media thickness of the ICA both predict
cardiovascular events, intima-media thickness of the ICA improves predictive power when
combined with Framingham risk factors to classify risk for cardiovascular outcomes39. In healthy
subjects, vessel wall volume provides a three-dimensional intima-media thickness measurement of
arterial wall hypertrophy for both CCA and ICA. Furthermore, elevated VWV may also provide an
early atherosclerosis measurement.
Second, we observed a positive and significant correlation between both intima-media thickness
and vessel wall volume with age in all subjects. Mean IMT for all subjects in this study was 0.87 ±
0.23 mm and in a systematic review, Aminbakhsh and Mancini

23

identified an increased risk of

stroke for IMT values greater than 0.75 mm and increased myocardial infarction risk when IMT
values were greater than 0.82 mm. We also observed that mean intima-media thickness was
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significantly higher in males than females, previously reported in the literature 24. The populationbased Tromsø study described the relationship of age with cardiovascular disease and reported an
increased incidence of cardiovascular disease in males with carotid plaque

29

. We observed that

VWV, essentially a 3D measurement of IMT and plaque, was also correlated with age, but only in
males.
Third, we observed that 3DUS VWV was not significantly associated with age in females, although
the relationship in females between IMT with age was positive. Because VWV is essentially a 3D
IMT and plaque measurement, we investigated the role of plaque in this relationship and measured
total plaque volume in females. For example, in the Tromsø study it was shown that menopause
may have had an adverse effect on atherosclerosis characterized by a curvilinear trend between
aging and plaque prevalence in women

29

. To provide a way to better understand these results, in

females only we evaluated the relationship of presence and volume of plaque (TPV) with IMT and
VWV. We were surprised to see only a modest but significant correlation (r = 0.37, p = 0.0008)
between IMT and VWV in females, and this association was not unexpected as IMT is essentially a
component of the VWV measurement. Differences in relationships with age may be explained by
the reactive changes in intima-media thickening due to increased blood pressure and shear stress
resulting from turbulent flow. In addition intima-media thickness changes during the cardiac cycle,
whereas cross-sectional area of IMT is thought to be constant

40,41

previously been shown between IMT and the presence of plaques

. Although correlations have
40

, there was no relationship

between IMT and TPV observed in this study. We did observe a modest relationship between
VWV and TPV in this study which was not unexpected because plaque is included in the vessel
wall volume measurement.
According to these findings we suggest there may be a clinical impact in interpreting ultrasound
scanning of the carotid artery. We hypothesize that plaque development in females may not be
related to age but may be influenced more by inflammation. Over half of the females included in
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this analysis were characterized by inflammatory processes such as rheumatoid arthritis and post
kidney transplantation.

As a result, traditional intima-media thickening may not be a good

prognostic indicator of cerebrovascular events in females. Three-dimensional ultrasound
measurements are more sensitive and may also provide a better estimate of risk in females.
Investigation into the pathophysiology of plaque development and its relationship to carotid
ultrasound imaging may provide a better understanding of the clinical meaning of ultrasound
measurements.
We must also acknowledge a number of study limitations that may limit our conclusions. For
example, correlations between age and ultrasound measurements did not control for a number of
cardiovascular risk factors because these were not available for all subjects. However, for a large
subset of the study sample (n=195), smoking history, systolic and diastolic blood pressure, HDL
cholesterol, LDL cholesterol, total cholesterol and triglycerides were recorded and adjusted for with
the result being the same positive associations. Although the relationship between age and intimamedia thickness has been well established in the literature, comparisons of age and 3DUS VWV
have never before been documented and this was the rationale for the current analysis. The current
results certainly motivate further research into determining the relationship between age and
imaging measurements in those with moderate disease and age-matched healthy subjects without
co-morbidities. We also recognize that the small number of females included in this analysis may
have limited the power to detect differences between the sexes in this study. Moreover, neither
menopausal state nor hormone replacement status were reported by our subjects so this information
could not be used when interpreting our results. Therefore, these preliminary findings should be
considered hypothesis-generating for future studies that evaluate the specific relationship between
age, sex and underlying disease in the generation and progression of carotid atherosclerosis.
The present study explores the relationship between ultrasound measurements of carotid
atherosclerosis with age and sex and is the first to describe the relationship between vessel wall
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volume, total plaque voulme and age.

Our results suggest that age and sex are significant

determinants of VWV even in subjects with risk factors and underlying atherosclerosis. Further
studies are required to identify abnormal vessel wall volume as it relates to age in healthy
individuals. We have previously shown VWV is a precise, non-invasive measurement with low
inter-and intraobserver variability5. The sensitivity of this measurement allows us to regionally
evaluate local thickening as temporal changes in VWV can be measured in as little as 12 weeks13.
Additionally, we have previously demonstrated changes in vessel wall volume in response to
therapy and dietary intervention 16. Recently, the VWV measurement has been semi-automated to
reduce segmentation time increasing its potential for clinical application in monitoring and
diagnosing atherosclerosis

19

.

Further investigation of 3DUS vessel wall volume and its

relationship to risk factors is required in order to determine its ability to predict cardiovascular
events and serve as a biomarker in clinical trials.

2.5 Conclusions
In a large group of subjects with a variety of diseases that include atherosclerosis as a co-morbidity
we observed that in all subjects intima-media thickness correlated with vessel wall volume but in
females VWV correlated with total plaque volume, and TPV did not significantly correlate with
intima-media thickness. Additionally, in all subjects, and in males alone, intima-media thickness
and 3DUS vessel wall volume were significantly associated with age. In females alone, intimamedia thickness was positively and significantly correlated with age, but 3DUS vessel wall volume
was not. Further analysis of plaque revealed that total plaque volume and age were not associated
in females.
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Chapter 3: Semi-automated Segmentation of Threedimensional Ultrasound Carotid Atherosclerotic Plaque
Volume
3.1 Introduction
Atherosclerosis in the carotid arteries manifests as plaque lesions that can lead to ischemic stroke.
In particular, it is the size, shape and composition of atherosclerotic plaque that are predictive of
stroke risk

1-4

. In this regard, in addition to monitoring traditional risk factors such as lipid

biomarkers and blood pressure, carotid imaging methods have also been developed for direct
measurements of carotid disease5. In clinical and diagnostic evaluations of carotid atherosclerosis,
magnetic resonance imaging and x-ray angiography methods may be used6, but Doppler ultrasound
measurements of carotid flow perturbations dominate because it is fast, portable, relatively
inexpensive, reliable and noninvasive 7-9.
For research studies of carotid atherosclerosis, B-mode ultrasound provides a direct, reliable and
relatively straightforward measurement of carotid intima-media thickness (IMT) and this has been
widely used and shown to correlate with important clinical outcomes such as stroke and mortality10,
11

. Components of the IMT are critical as Finn et al described that common carotid artery (CCA)

IMT without atherosclerotic plaque is more reflective of hypertensive medial hypertrophy than
atherosclerosis itself

12

and has been shown to be an indicator of hypertension

13, 14

. Moreover,

plaque is not often included in the IMT measurement although plaque appears to be a better
predictor of inflammation than IMT alone 15.
Independent of IMT, the measurement and monitoring of carotid plaque itself has been shown to be
important for stroke risk stratification and prognosis

16-18

. For example, plaque area and volume

measured in the internal carotid artery have been shown to be better predictors of inflammatory
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disease and myocardial infarction

13, 15

compared to IMT. In fact the Norwegian Tromsø 10-year

follow up study of ischemic stroke risk suggested that plaque area was a stronger predictor of
ischemic stroke than IMT19.

Total Plaque Area (TPA) is a 2D estimation of plaque in the

longitudinal plane8. While this cross-sectional area provides a rapid estimation of plaque area,
measurement variability is inherently high because image acquisition depends on repeatedly
selecting the same representative longitudinal view for each new measurement. Importantly, while
TPA

changes approximately 10 mm2/year20 annual IMT changes are approximately half the

resolution of ultrasound 21, which makes US detection of changes in IMT impossible under normal
circumstances.
To address this limitation and others associated with B-mode carotid IMT, three-dimensional
ultrasound (3DUS) imaging phenotypes have been developed including vessel wall volume22-25, and
total plaque volume (TPV)

26-32

. 3D ultrasound volumetric measurements have been shown to be

more sensitive to change in the vessel wall as significant changes in arterial wall volume have been
observed in response to statin therapy and dietary intervention in as little as twelve weeks. Although
3D measurements such as TPV provide estimates of plaque volume that encompasses the complex
geometries and morphologies associated with plaque

31, 33

their use is limited to research studies.

Current manual segmentation of these 3D measurements is laborious and time-intensive limiting
their potential for wide application in the clinical setting.
While TPA (measured in the longitudinal view) and manual TPV (measured in the axial view) are
measured in a single plane only, our aim was to generate a method that incorporated information
from both the longitudinal and axial views, maximizing the use of the 3DUS information to
approximate TPV. In other words, we aimed to incorporate the longitudinal view - ideal for rapidly
identifying the ends of a plaque, and the cross-sectional axial view measurements – ideal for
providing information on plaque morphology in our semi-automated approach. Unfortunately there
is currently no clinically acceptable tool that is capable of generating reproducible, direct
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measurements of plaque alone. Accordingly, our objective was to generate a semi-automated
approach quantifying plaque volume to enable real-time bedside measurement requiring reduced
segmentation time and complexity in decision making.

3.2 Methods
3.2.1 Study Images
Carotid plaque lesions were analysed from 3DUS carotid images acquired in subjects with
asymptomatic carotid stenosis greater than 60% as determined by carotid Doppler ultrasound and
recruited from The Premature Atherosclerosis Clinic (London, Ontario, Canada) or from those who
had consented to participation in the Dietary Intervention to Reverse Atherosclerosis Trial with
body mass index (BMI) ≥27 kg/m2 as previously described18, 34. Each study protocol was approved
by a local research ethics boards and all subjects provided written informed consent.

3.2.2 Image Acquisition
To acquire 3DUS images, an ultrasound probe (L12-5, 50 mm, Philips, Bothell, WA, USA) was
translated along the subjects’ neck at 3mm/s using a mechanical device that guided the transducer
along a fixed path and at uniform speed. 2D frames were acquired from the ultrasound system
(ATL HDI 5000, Philips) in an axial direction for 4 cm of the neck. An 8.5MHz transducer
captured several parallel 2D frames separated by 0.15 mm, which were digitized and saved. The
image frames were reconstructed into a 3D image based on weighted pixel intensities values using a
3D Echotech system (GE Medical Systems, Milwaukee, Wis).
optimized for each patient scanned.

Ultrasound parameters were
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3.2.3 Image Analysis
In total 23 different carotid plaque lesions were selected for analysis to represent a range of plaque
sizes and volumes within close proximity to the carotid bifurcation -5 mm into the internal carotid
artery and 25 mm into the common carotid artery from the flow divider. Two observers measured
all 23 plaques once using manual planimetry and using semi-automated segmentation on multiple
occasions.
To evaluate repeated measurements made within a single three-to-five minute period – referred to
in this work as 5 minute repetitions - five consecutive semi-automated segmentation measurements
were made for each plaque by both observers with observers blinded to subject clinical status. To
evaluate repeated measurements made within a week, both observers also completed repeated
measurements of each plaque five times over a 5 day period with a 20 hour gap – referred to as 20
hour repetitions - between measurement sessions. As previously described, we defined TPV as the
sum of all plaque volumes within a single subject including both common and internal carotid
arteries. Typically, left and right sides were summed to generate a cumulative TPV for each subject.
However, for the analysis presented here, each individual plaque was evaluated independently for
comparison of manual and semi-automated methods.

3.2.4 Manual Segmentation
Methods previously described were employed for the manual measurement of carotid plaque
volume 33. Briefly, the user identified the bifurcation of the common carotid artery and selected a
parallel axis for segmentation.

An Intuos3 professional pen tablet (Wacom Technology

Corporation, Vancouver, WA, USA) was used to manually segment plaque boundaries.
Initialization of the measurement occurred in the axial plane whereby the beginning of the plaque
was identified and a contour was drawn to generate a cross-sectional area. Plaque segmentation
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along the parallel axis at 1mm interslice distances was performed until the entire plaque was
measured. Cross-sectional areas were multiplied by the inter-slice distance to compute a volume.

3.2.5 Semi-Automated Segmentation Methodology
The algorithm that we developed to measure TPV semi-automatically takes advantage of the fact
that in a 3DUS volume, both the longitudinal and axial views provide a way to estimate the ends of
each plaque and the morphology across each individual plaque.
The first step involved the observer using the 3DUS volume in the longitudinal and axial planes to
identify the estimated ends of a single plaque visibly obvious as echogenic plaque. The second step
involved identification of the estimated midpoint of the plaque in the longitudinal plane and a
contour generated from this midpoint (Contour 1, C1). From C1, the minimum and maximum
values along the z-axis were identified by the algorithm as the end points of the plaque. To assist
with geometric approximation of the entire plaque volume, three additional boundaries in the
longitudinal view were generated by the user (Contour 2, C2; Contour 3, C3 and Contour 4, C4).
Finally, the maximum and minimum z values (end points) were automatically joined to 20 points
along C2 and C4. Additionally, the same number of points on C3 was connected to points on C2
and C4. Figure 3-1 shows contours from the view of the sonographer (top row) and an algorithm
schematic view of contour placement within the plaque (bottom row) used to estimate plaque
volume.
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Figure 3-1. Observer input for semi-automated TPV measurement. In the longitudinal view
(and with assistance from the axial view, not shown) the user identifies the maximum and minimum
z-values representing the end points of the plaque (Min Z and Max Z). The user identifies the
longitudinal mid-point of the plaque (C1) and finally C2, C3, andC4 are identified and generated.
Uniform plaque geometry between C2 and C3 as well as C3 and C4 is assumed and a final volume
is generated.

The points along C2, C3 and C4 were linearly interpolated to generate triangular surface areas. The
resulting geometric approximation was a polyhedron with several surface areas (Ai) where m faces
(Fj) labelled F0,…Fm-1 were used to compute a volume 35 as shown in equation 1 below.

V=

1 m-1
1 m-1
•
P
A
=
PFj • (2A j )
∑ Fj j 6 ∑
3 j=0
j= 0

(1)

From a single face of the enclosed volume, the surface area is multiplied by a height, which was
established by isolating the y-component of a vector that extended from the surface of the face to a
representative vertex within the volume as shown in Figure 3-2.
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Figure 3-2. Geometric approximation for semi-automated TPV measurement. From the
observer input, several triangular surface areas are generated to approximate the enclosed volume.

For semi-automated segmentation, prior to establishing segmentation boundaries the observer
identified the bifurcation and set a parallel axis for segmentation. Plaque boundaries were defined
as a distinct increase in wall thickening in comparison to neighbouring wall accompanied with
hyperechoic signal. From the marked bifurcation, a point was placed 10 mm into the common
carotid artery in the center of the lumen. A second point was placed 5 mm in the center of the
lumen of the internal carotid artery. The longitudinal plane was manipulated until both points were
in view creating an axis along the artery from the common carotid to the internal carotid artery.
After establishing an axis of segmentation, a two-plane approach was used to estimate plaque
volume as described in Figure 3-3.
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Figure 3-3. Semi-automated total plaque volume measurement pipeline.

3.2.6 Statistical Analysis
Intra-observer variability was assessed using the intra-class correlation coefficient (ICC) for both
five repetitions within 5 minutes and five repetitions separated by 20 hours to assess the intra- and
inter- reliability. Coefficient of variation (standard deviation of five independent measurements
divided by the mean) for each plaque was also calculated for all five repeated semi-automated
measurements. Semi-automated measurements were compared to manual segmentations using
linear regression, Pearson correlation coefficient and Bland Altman plots.

Linear regression was
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performed with GraphPad Prism version 4.01 for Windows (GraphPad Software, La Jolla, CA,
USA). Additionally the ICC was used to identify the intra – and inter-observer variability between
observers. A repeated measures ANOVA was performed to compare repeated plaque volume
measurements. Statistical analyses such as paired t-tests and ANOVA were performed using IBM
SPSS Statistics v. 19 (SPSS Inc, Chicago, Ill, USA). In all statistical analyses, results were
considered significant when the probability of making a Type I error was less than 5% (p < 0.05).

3.3 Results
Each observer completed five consecutive repetitions to yield a mean plaque volume for all 23
plaques. The mean plaque volume measurements for each observer are reported in Table 1.
Repeated measurements were made same-day within 5 minutes of each other and generated a semiautomated mean plaque volume of 92.5 ± 8.9 mm3 for Observer 1 while the mean plaque volume
was 82.8 ± 8.3 mm3 for Observer 2. Plaque volume measurements were also performed five times
with 20 hours separating repetitions. Mean semi-automated plaque volume for Observer 1 for 20
hour measurements was 92.7 ± 11.8 mm3 and 83.1 ± 7.8 mm3 for Observer 2. Measurements from
both observers for 5 minutes and 20 hour repetitions were grouped and a paired samples t-test
indicated no significant difference between measurements (p = 0.766).
measurementsbetween observers were also not significantly different (p = 0.355).

Plaque volume
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Table 1. Mean semi-automated plaque volumes and intra-observer comparisons. Intraobserver variability reported by coefficient of variation.
Observer 2

Observer 1
5 Minutes
SA PV
( ±SD
Plaque
ID
in mm3)
1-1
89.6 ± 10.4
2-1
26.3 ± 1.8
2-2
39.9 ± 3.6
3-1
283.7 ± 18.1
4-1
147.6 ± 1.1
7-1
58.0 ± 2.9
7-2
95.3 ± 5.0
8-1
26.3 ± 2.1
8-2
61.8 ± 4.9
10-1
165.2 ± 7.8
11-1
54.7 ± 2.9
12-1
16.8 ± 1.0
14-1
76.1 ± 4.2
15-1
21.3 ± 2.5
19-1
85.4 ± 9.2
22-2
13.4 ± 0.8
22-3
35.3 ± 1.0
23-1
287.1 ± 18.8
24-1
280.2 ± 22.4
25-1
138.5 ± 8.5
25-2
28.4 ± 2.8
27-1
30.5 ± 3.4
27-2
66.3 ± 12.6
Mean
92.5 ± 8.9

CV
(%)
11.6
6.9
9.1
6.4
0.7
5.1
5.3
8.1
7.9
4.7
5.3
6.1
5.5
11.7
10.7
5.6
2.7
6.5
8.0
6.1
9.9
11.3
18.9
9.6

20 hours
SA PV
( ±SD
in mm3)
77.9 ± 4.0
23.2 ± 1.2
44.1 ± 4.3
272.3 ± 15.8
145.3 ± 10.5
53.5 ± 5.6
97.1 ± 6.2
26.5 ± 2.3
66.1 ± 9.7
167.0 ± 8.8
65.2 ± 8.5
19.0 ± 1.3
75.5 ± 5.5
22.4 ± 2.8
85.1 ± 3.2
12.8 ± 0.7
36.2 ± 2.7
294.6 ± 34.4
276.3 ± 27.7
159.1 ± 17.2
27.2 ± 4.1
28.8 ± 4.9
56.9 ± 10.7
92.7 ± 11.8

CV
(%)
5.1
5.3
9.7
5.8
7.3
10.5
6.4
8.5
14.6
5.3
13.1
6.8
7.3
12.3
3.7
5.3
7.4
11.7
10.0
10.8
15.0
17.0
18.7
12.7

5 Minutes
SA PV
( ±SD
in mm3)
87.9 ± 2.4
13.5 ± 1.7
30.1 ± 1.9
256.6 ± 19.0
109.5 ± 9.0
48.8 ± 3.3
74.6 ± 6.1
41.6 ± 3.1
81.2 ± 7.2
118.1 ± 11.0
72.0 ± 5.3
23.6 ± 1.2
123.8 ± 16.0
31.7 ± 3.1
39.7 ± 3.5
10.7 ± 0.7
32.1 ± 3.3
190.7 ± 12.4
239.5 ± 14.8
201.6 ± 13.6
21.2 ± 2.0
18.4 ± 1.8
37.5 ± 2.4
82.8 ± 8.3

CV
(%)
2.7
12.3
6.2
7.4
8.3
6.7
8.1
7.4
8.9
9.3
7.3
5.2
13.0
9.9
8.9
6.7
10.1
6.5
6.2
6.7
9.5
9.9
6.4
10.0

20 hours
SA PV
( ±SD
in mm3)
89.0 ± 3.4
14.6 ± 1.0
30.9 ± 2.9
253.3 ± 16.2
111.9 ± 13.7
51.7 ± 3.3
75.3 ± 6.0
46.1 ± 3.3
83.1 ± 8.6
116.3 ± 8.5
74.6 ± 4.2
26.6 ± 1.9
100.5 ± 6.0
29.2 ± 2.8
37.3 ± 2.6
11.0 ± 1.3
33.0 ± 3.2
206.5 ± 13.1
249.3 ± 18.7
180.9 ± 9.8
23.2 ± 2.9
21.4 ± 2.6
45.8 ± 4.3
83.1 ± 7.8

CV
(%)
3.8
6.6
9.5
6.4
12.3
6.5
7.9
7.2
10.4
7.3
5.6
7.0
6.0
9.5
6.9
12.2
9.6
6.4
7.5
5.4
12.4
12.3
9.3
9.4

Manual measurements for all 23 plaques were completed once by both observers. Manual plaque
volume measurements were not significantly different (

= 107.6 mm3) for Observer 1 when

compared to mean 5 minute repetitions (p = 0.603) and mean plaque volume for 20 hour repetitions
(p = 0.608). Similar analyses were also performed for Observer 2 comparing the mean of the
manual measurement round (

= 99.0 mm3) to mean semi-automated plaque volumes

measurements for 5 minute (p = 0.497) and 20 hour (p = 0.503) repetitions. Figure 3-4 shows semiautomated measurements and manual segmentation boundaries for a plaque < 100 mm3 (top) and >
100 mm3 (bottom).
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Figure 3-4. Representative manual and semi-automated segmentation boundaries. Semiautomated measurements (blue) and manual segmentation boundaries (red) in axial (left) and
longitudinal (right) views for a plaque < 100 mm3 (top) and > 100 mm3 (bottom).
Yellow bar represents 10mm.

Coefficient of variation was calculated for each plaque at both time spans and for both observers
and is reported in Table 1 along with mean volume measurements for each plaque. Intra-observer
variability for 5 minute repetitions was reported with a CV of 9.6% for Observer 1 and 10% for
Observer 2. Coefficient of variation for 20 hour repeated measurements was 12.7% for Observer 1
and 9.4% for Observer 2. The relationship between coefficient of variation and the mean semiautomated plaque volume is shown in Figure 3-5 for each measurement time span.
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Figure 3-5. Relationship of semi-automated plaque volume and variability of measurement
(CV). Intra-observer variability is represented by the coefficient of variation (CV) for 5 minute
repeated measurements (triangle) and measurements separated by 20 hours (circle) plotted against
mean semi-automated plaque volume (SA PV) for Observer 1 (left) and Observer 2 (right).

Five minute measurement repetitions were compared using a repeated measures ANOVA and were
not significantly different for Observer 1 (p = 0.68, sphericity assumed). However, for Observer 2
repetitions separated by 5 minutes were statistically significant after correcting for violations of
sphericity (p = 0.042, Green-house Geisser correction). Measurement rounds were not significantly
different at 20 hour time-gaps for either Observer 1 (p = 0.120, Green-house Geisser correction) or
Observer 2 (p = 0.053, Green-house Geisser correction).
The intraclass correlation coefficient for absolute agreement was significant (p < 0.001) for 5
minute repeated measurements (ICC = 0.990) and 20 hour repeated measures (ICC = 0.982) for
Observer 1. Observer 2 also demonstrated significant correlations for 5 minute (ICC = 0.988) and
20 hour (ICC = 0.989) time spans. The ICC was also utilized to analyze the inter-observer
variability between observers for different measurement time spans. Observer measurements were
strongly significantly correlated for 5 minute (ICC = 0.911) and 20 hour time-gaps (ICC = 0.940).
Semi-automated measurements were compared with the reference standard, manual planimetry.
Mean semi-automated plaque measurements were highly correlated with manual measurements for
both 5 minute measures in both Observer 1 (r2 = 0.96, p < 0.001) and Observer 2 (r2 = 0.97, p <
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0.001) and similarly for 20 hour measures in Observer 1 (r2 = 0.97, p < 0.001) and Observer 2 (r2 =
0.99, p < 0.001). Results from linear regression analysis are shown in Figure 3-6.

Figure 3-6. Linear regression analysis for manual and semi-automated plaque measurements.
Semi-automated plaque volume (SA PV) plotted against manual plaque volume (PV) for Observer
1 (left) and Observer 2 (right) 5 minute repeated measurements (top) and measurements separated
by 20 hours (bottom). Dotted lines represent 95% confidence interval.

Bland Altman plots show high agreement between measurements methods as indicated by the
confidence limits shown in Figure 3-7. The bias for Observer 1 for 5 minute measurements was 15.11 mm3 while the 20 hour repeated measures bias was -14.91 mm3.

Observer 2 also

demonstrated a negative bias of -16.23 mm3 for 5 minute repeated measurements and -15.93 mm3
for 20 hour repeated measures.
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Figure 3-7. Bland Altman analysis of agreement between semi-automated and manual
measurement methods. Absolute difference between mean semi-automated total plaque volume
(SA TPV) and manual total plaque volume (M TPV) plotted against the mean of manual and the
mean semi-automated plaque volumes. Analysis for Observer 1 (left) and Observer 2 (right) 5
minute repeated measurements (top) and measurements separated by 20 hours (bottom). Limit of
agreement is indicated by the dotted lines representing 95% level of confidence.

3.4 Discussion
We have validated a novel semi-automated approach for measurement of total plaque volume and
made two central observations: 1) we have demonstrated the semi-automated plaque volume
measurement is reproducible; 2) there is considerably high accuracy between manual planimetry
and semi-automated total plaque volume measurements. Total plaque volume has been correlated
to cardiovascular events such as stroke20. Measurement of plaque size is important in quantifying
risk for stroke and determining treatment36. 3D ultrasound plaque volume measurements have
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shown significant changes in response to statin therapy18. However, plaque volume estimation
using 3DUS has been limited in the past due to long measurement times and specialized training.
We hypothesized that faster semi-automated measurements would share similar intra- and interobserver variability and accuracy to established manual methods.
The intra-observer variability of both observers was analyzed for measurements completed within 5
minutes.

Highly correlated ICC values and low coefficient of variation values indicate low

variability. Coefficient of variation decreased with increasing plaque volume for both 5 minute and
20 hour measurements, which has been previously reported31.

Manual plaque volume

measurements have been reported by Landry et al.31 and thus were not repeated here. From this
previous work the relationship between manual plaque volume measurements and CV was
interpolated using the mean of our manual measurements. For a mean of approximately 100 mm3,
Landry et al. report a manual CV of 10% which is similar to the values we have reported for semiautomated measurements. Additionally, the reproducibility was high between observers as reported
by high ICC values indicating that observers are functionally equivalent. Semi-automated plaque
volume estimates separated by 20 hours did not produce statistical differences suggesting that time
between measurements did not affect variability.
Secondly, the accuracy of semi-automated measurements was determined using manual
measurements as a reference standard. Manual planemitry and semi-automated measures were
significant and highly correlated. In line with results of the linear regression analysis, Bland
Altman plots indicated high agreement between the two methods as data comparing absolute
differences between methods to the average of both methods were within confidence limits.
However, the semi-automated measurement was biased in that it underestimated manual
measurements. The margin of underestimation was similar for 5 minute and 20 hour repetitions.
This underestimation bias could be eliminated by performing longitudinal comparisons. Change in
plaque would not be influenced by the bias as it remains consistent between time points.
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While the semi-automated measurement can be made in just over a minute, we acknowledge there
are certain limitations that may affect the utility of this measurement.

Manual planimetry

measurements were used as the reference standard however these measurements have yet to be
validated with histology. Future validation of plaque histology to 3DUS imaging is essential in
ensuring imaging measurements accurately estimate true changes in plaque size. Additionally, the
semi-automated plaque volume algorithm uses a geometric approach to quantify plaque size and
does not incorporate image information such as global or local region boundary analysis and pixel
intensity information. A semi-automated geometric approach does however offer certain benefits
over automated methods in that the observer can compensate for shadowing and other artefacts
from surrounding structures. Finally, although the first set of measurements for the 20 hour data set
was acquired from the first round of the 5 minute dataset, after excluding these rounds in grouped
measurement comparisons from both observers the significance of the paired samples t-test did not
change (p = 0.766) when comparing 5 minutes and 20 hour repetitions.
In conclusion, we have developed a geometrically based semi-automated total plaque volume
segmentation measurement that is reproducible and accurate while reducing measurement time.
Repeated measurements at 5 minute and 20 hour time gaps have demonstrated low variability
within and between observers.

Estimation of plaque with semi-automated methods is highly

correlated with manual measurements providing accurate estimates when compared to manual
measurements. This method has clinical potential for the estimation of plaque burden and could
play an important role in monitoring of plaque progression and regression over time.
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Chapter 4: Conclusions and Future Work
4.1 Summary
Current clinical tools and measurements that are used to evaluate and characterize coronary and
carotid atherosclerosis are limited in their ability to provide rapid and direct measurements of
atherosclerotic plaque. In other words, while a number of indirect biomarkers have been developed
as surrogate measurements of plaque,1-4 carotid artery imaging is the only way to provide direct in
vivo and non-invasive or minimally invasive measurements of atherosclerosis.

In this regard, carotid ultrasound imaging has been developed to provide 1D, 2D and 3D
measurements of arterial wall and plaque5-7 as well as compositional imaging.8, 9 Most commonly,
carotid atherosclerosis has been characterized using Doppler ultrasound measurements of flow and
stenosis and B-mode ultrasound measurements of the common carotid artery intima media
thickness (IMT) which has been correlated with adverse CV events10. Although B-mode US IMT
alone does not include a measurement of plaque, 3DUS measurements can provide more sensitive
measurements of wall thickening than IMT and offer direct estimates of plaque area and volume6, 7,
11-14

. 3DUS image acquisition is safe, inexpensive and fast15, however 3DUS image measurements

are limited due to time consuming manual image analyses. In addition, the true clinical meaning of
3DUS carotid imaging measurements has not yet been established in cross-sectional or longitudinal
outcome studies.
Therefore, the overarching aim of this thesis was to extend the previous work of our team to
develop a more automated 3DUS carotid atherosclerosis measurement method and a better
understanding of cross-sectional 3DUS measurements of carotid atherosclerosis in vulnerable
populations. The aims of this thesis were to: 1) generate a better understanding of the clinical
meaning of 3DUS carotid atherosclerosis and show how these measurements relate to traditional
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risk factors of atherosclerosis 2) to identify their relationship with established imaging phenotypes
and 3) to increase the clinical and research utility of 3DUS total plaque volume measurements by
automating its measurement for use at the bedside in real-time.
The primary objective of this thesis was to establish the relationship between 3D ultrasound
measurements and traditional risk factors for stroke. We hypothesized that we would observe a
similar relationship of VWV with age and sex as observed with carotid IMT. Chapter 2 provided
the results of the analysis of the relationship between ultrasound measurements of B-mode US IMT,
and 3DUS VWV and TPV with age and sex in over 300 subjects with mild to moderate
atherosclerosis.

This was the largest 3DUS atherosclerosis imaging retrospective analysis

accomplished to date incorporating subject populations with stroke co-morbidities such as diabetes,
obesity, arthritis and post-surgical intervention. In this analysis we showed a significant correlation
of IMT with age, for all subjects and both sexes which is a finding that has been reported in the
past.16-18 While in all subjects and in males only 3DUS VWV correlated with age, in females we
observed that although IMT was significantly associated with age, VWV was not. Since VWV is
essentially 3D IMT+TPV, the relationship between age and TPV was also analyzed in females.
The relationship between age and TPV was not significant. Due to the large role of inflammation in
the co-morbidities included in our analysis we suggested that plaque development in females may
be dependent on inflammation and not age.
The secondary objective of this thesis was to develop and test a semi-automated measurement of
carotid TPV measurements to improve the utility of TPV as a surrogate for carotid artery disease.
Chapter 3 outlined the development and application of a semi-automated TPV measurement and
extends our preliminary results submitted and accepted for presentation and publication (see
Appendix B). Motivating this development was the fact that manual 3DUS measurements of TPV
can require up to 1 hour of image analysis per image and this has certainly limited translation to
large-scale clinical trials and real-time patient monitoring in the clinic.

For example, the
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identification of vessel wall boundaries, establishing segmentation axes, determining plaque
boundaries, distinguishing artefacts and interpreting slice-specific boundaries all contribute to
increased measurement times. Automating aspects of this measurement should reduce the time
required for image analysis and allow for real-time bedside measurements.

To address this

problem, we generated a way to approximate TPV and evaluated variability using images from
subjects with severe atherosclerosis and stenosis >60%. We showed low variability as reported
with low coefficient of variation and high intraclass correlation coefficients for intra- and interobserver variability. Additionally, Bland Altman and linear regression analysis reported high
agreement between manual and semi-automated measurement methods. Our analyses also revealed
an underestimation bias in semi-automated measurements.

4.2 Limitations of Current Work and Unanswered Questions
We identified a number of limitations in our development of semi-automated segmentation of TPV
and as well in exploring the relationship of VWV with age and sex.
In Chapter 2, while ultrasound measurements were compared with each other and to age and sex,
the association of these measures in relation to other cardiovascular risk factors could not be
determined in our study. Additionally, the effect of endogenous hormones or hormone replacement
therapy could not be accounted for in our analysis. Our database was created following the
acquisition of images for each population group and as such data for other biomarkers was not
consistently acquired from each group. Subjects scanned were included in analysis if age and
gender were recorded or could be obtained from patients who were not lost to follow-up and images
were of sufficient quality for all ultrasound phenotypes. For the obese subjects, 35 were excluded
due to poor image quality, for diabetics, 12 were excluded due to poor imaging quality, for the posttransplant subjects, age was not recorded for 8 patients and they were lost to follow-up and for RA
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subjects, 6 subjects did not have suitable image quality for analysis. While imaging measurements
from the studies in this thesis were performed retrospectively, there is potential to eliminate this
image quality limitation using semi-automated measurements. Operators can scan the patient and
analyze the image with the patient in the room allowing for rescan if image quality is insufficient.
Limitations were also identified specific to the development of semi-automated TPV measurement.
While observers measured plaques with the criterion that hyperechoic signal combined with notable
wall thickening constituted plaque, no objective measure was used to define plaque. Subsequently,
this could be a source of observer variability between plaque measurements. Additionally, while
TPV has been reported as the sum of plaques in the left and right carotid arteries, in this thesis we
defined it as the mean of both sides for comparison to VWV which was also determined as the
mean of left and right arteries.

4.3 Future Work and Clinical Applications
All of the limitations of our current analysis and results certainly motivate the direction of future
work. For example, a better understanding of the clinical meaning of 3DUS imaging measurements
will require a comparison of 3DUS measurements with clinically established but less indirect
biomarkers such as c-reactive protein, lipoprotein (a), fibrinogen and homocysteine. Differences
observed in relation to traditional ultrasound measurements suggest that 3DUS measures may
provide unique information pertaining to atherosclerosis. Further analyses of these semi-automated
measurements will also help to establish the clinical use of these phenotypes. Prospective studies
comparing those with mild, moderate and severe disease to sex- and age-matched controls will
allow us to improve our understanding of the effects of hormones, inflammation and modifiable risk
factors in carotid artery atherosclerosis.
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Future work for the development of the semi-automated TPV measurement will focus on improving
the accuracy of the tool compared to manual segmentation.

While a geometric approach is

preferred to accurately estimate plaque even when artefacts are present, a level set method could be
applied exclusively to the axial segmentation boundaries to combine input from the observer with
voxel information from the image.

Additionally, the optimal number of axial segmentation

boundaries used to generate a volume will be analyzed to improve overall accuracy.
Semi-automated total plaque volume is currently being applied in measurements of plaque for two
studies.

One study is exploring the safety of a commonly prescribed immunosuppressant in

comparison to traditional standard of care using imaging measures of semi-automated IMT, and
VWV alongside TPV.

The second study explores the effects of mild to moderate alcohol

consumption on atherosclerosis using imaging endpoints. In each study traditional biomarkers such
as age, cholesterol levels, blood pressure and other traditional cardiovascular risk indicators are
collected in combination with emerging biomarkers such as c-reactive protein, homocysteine and
other measurements. Longitudinal studies such as these will improve our understanding of 3DUS
measurements and their relationship to cardiovascular events and other biomarkers.
We hypothesized that three-dimensional ultrasound measurements of carotid atherosclerosis can
provide a more sensitive estimation of disease burden in vulnerable patient populations than
traditional measures. In this thesis we have attained our objective of characterizing the relationship
of three-dimensional ultrasound vessel wall volume with age. We have demonstrated with age and
sex a novel relationship between 3D imaging biomarkers that is nonexistent with 1D US
measurements. While 3DUS measurements show similar trends of plaque and IMT with age in
males, this relationship does not exist in females as inflammation may play a larger role in plaque
development in females. Secondly, we have developed a novel semi-automated approach for the
estimation of total carotid plaque volume with similar variability and high agreement with manual
measurements.

The objectives described here were developed to provide rapid estimation of
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atherosclerotic disease and improve our understanding of interpreting 3DUS measurements as they
relate to cerebrovascular event risk. Development and understanding of current and emerging
biomarkers will serve to increase our understanding of atherosclerosis as a disease process and lead
to more effective strategies for prevention, monitoring and treatment of cardiovascular disease.
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Appendix B
Semi-automated segmentation of carotid artery total plaque volume
from three dimensional ultrasound carotid imaging
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Imaging Research Laboratories, Robarts Research Institute, bDepartment of Medical Biophysics,
c
Biomedical Engineering Graduate Program, The University of Western Ontario,
London, Ontario, Canada
ABSTRACT

Carotid artery total plaque volume (TPV) is a three-dimensional (3D) ultrasound (US) imaging measurement of carotid
atherosclerosis, providing a direct non-invasive and regional estimation of atherosclerotic plaque volume – the direct
determinant of carotid stenosis and ischemic stroke. While 3DUS measurements of TPV provide the potential to
monitor plaque in individual patients and in populations enrolled in clinical trials, until now, such measurements have
been performed manually which is laborious, time-consuming and prone to intra-observer and inter-observer variability.
To address this critical translational limitation, here we describe the development and application of a semi-automated
3DUS plaque volume measurement. This semi-automated TPV measurement incorporates three user-selected
boundaries in two views of the 3DUS volume to generate a geometric approximation of TPV for each plaque measured.
We compared semi-automated repeated measurements to manual segmentation of 22 individual plaques ranging in
volume from 2mm3 to 151mm3. Mean plaque volume was 43±40 mm3 for semi-automated and 48±46 mm3 for manual
measurements and these were not significantly different (p=0.60). Mean coefficient of variation (CV) was 12.0±5.1%
for the semi-automated measurements.
Keywords: 3D ultrasound, carotid, total plaque volume, segmentation, semi-automated, validation

1. DESCRIPTION OF PURPOSE
Carotid atherosclerosis progresses from an initial thickening of the intima and media layers of the arterial wall and
manifests as complex plaque lesions within the arterial wall and eventual stenosis that can potentially result in ischemic
stroke1. In order to monitor plaque development in patients at risk and to track the effects of new therapies direct, noninvasive and local measurements of plaque are required2-4. Ultrasound (US) imaging of the carotid arteries provides a
noninvasive way to monitor the progression and regression of atherosclerosis5,6. Although several 3DUS imaging
phenotypes have been developed7, there is currently no way to generate reproducible, direct measurements of plaque in
real time at the bedside and this is critical for translation of these measurements to clinical use and clinical trials. Total
Plaque Area (TPA) is a 2D estimation of plaque in the longitudinal plane8. While this cross-sectional area provides a
rapid estimation of plaque area, measurement variability is inherently high because image acquisition depends on
repeatedly selecting the same representative longitudinal view for each new measurement. In contrast, Total Plaque
Volume (TPV) provides a plaque estimation that encompasses the complex geometries and morphologies associated
with plaque9,10 but manual segmentation is laborious, time-intensive and has high intra- and inter-observer variability.
Accordingly, our objective was to generate a semi-automated method that can be used in real time for quantifying
plaque volume with precision similar to manual methods. While TPA (measured in the longitudinal view) and manual
TPV (measured in the axial view) are measured in a single plane only, our aim was to generate a method that
incorporated information from both the longitudinal and axial views, maximizing the use of the 3DUS information to
approximate TPV. In other words, we aimed to incorporate the longitudinal view - ideal for rapidly identifying the ends
of a plaque and the cross-sectional axial view measurements – ideal for providing information on plaque morphology in
our semi-automated approach.

2. METHODS
2.1 Imaging
3DUS images of the carotid arteries of ten subjects with carotid stenosis greater than 60% (defined by carotid Doppler
flow velocities) were evaluated for the measurement of 22 individual plaques in the common and internal carotid
arteries. Subjects recruited from The Premature Atherosclerosis Clinic (London Health Sciences Centre, London,
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Ontario, Canada) provided written informed consent to the protocol approved by the local ethics review board.
Ultrasound images were acquired using a Philips ATL HDI 5000 machine by translating an 8.5MHz ultrasound
transducer (L12-5, 50 mm, Philips, Bothell, WA, USA) along the lateral side of the neck. Parallel 2D images separated
by 0.15mm were acquired at a uniform speed of 3mm/s for 4.0cm along the neck without cardiac gating. After
completing acquisition, all 2D images were reconstructed into a 3D volume. Since the position and orientation of each
2D image was known, voxel based reconstruction allowed for each 2D image to be transformed within the 3D volume
as previously described11.
2.2 Manual segmentation
We used methods previously described for the manual measurement of TPV 41. Briefly, the user identified the
bifurcation of the common carotid artery and selected a parallel axis for segmentation in the 3DUS volume. An Intuos3
professional pen tablet (Wacom Technology Corporation, Vancouver, WA, USA) was used to manually segment plaque
boundaries. Initialization of the measurement occurred in the axial plane whereby the end of the plaque was identified
and a contour was drawn to generate a cross-sectional area. Plaque segmentation along the parallel axis at 1mm interslice distances was performed until the entire plaque was measured. Cross-sectional areas were multiplied by the interslice distance to generate volumes for individual plaques. For each subject, TPV was generated as the sum of all
plaques measured on the left and right carotid artery. Manual measurements were timed with a stopwatch initiated after
setting the bifurcation point.
2.3 Semi-automated segmentation: development and application

Figure 1. 3DUS TPV measurement algorithm pipeline.

The algorithm that we developed to measure TPV semi-automatically takes advantage of the fact that in a 3DUS
volume, both the longitudinal and axial views provide a way to estimate the ends of each plaque and the morphology
across each individual plaque. The algorithm pipeline is summarized in Figure 1. The first step involved the observer
using the 3DUS volume in the longitudinal and axial planes to identify the estimated ends of a single plaque visibly
obvious as echogenic plaque. The second step involved identification of the estimated midpoint of the plaque in the
longitudinal plane and a contour generated from this midpoint (Contour 1, C1). From C1, the minimum and maximum
values along the z-axis were identified by the algorithm as the end points of the plaque. To assist with geometric
approximation of the entire plaque volume, two additional points in the longitudinal view were generated by the user
(Contour 2, C2 and Contour 3, C3). Finally, the maximum and minimum z values (end points) were automatically
joined to 20 points along C2 and C3.
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Figure 2. User input for semi-automated TPV measurement. In the longitudinal view (and with assistance from the axial view,
not shown) the user identifies the maximum and minimum z-values representing the end points of the plaque (Min Z and Max Z).
The user identifies the mid-point of the plaque (C1) and finally C2 and C3 are identified and generated. Uniform plaque geometry
between C2 and C3 is assumed and a final volume is generated.

The points along C2 and C3 were used as representative vertices (PFj) and linearly interpolated to generate surface
areas. The resulting geometric approximation was a polyhedron with several surface areas (Ai) where m faces (Fj)
labeled F0,…Fm-1 were used to compute a volume12 as shown in equation 1 below. The time to perform measurements
was measured automatically using a timer that was built into the measurement software. The user activated the timer
prior to beginning the measurement and stopped timing after the algorithm generated a plaque volume.

V=

1 m-1
1 m-1
•
P
A
=
PFj • (2A j )
∑ Fj j 6 ∑
3 j=0
j= 0

(1)

2.4 Evaluation
As previously described, we defined TPV as the sum of all plaque volumes within a single subject including both
common and internal carotid arteries. Typically, left and right sides were summed to generate a cumulative TPV for
each subject. However, for the analysis presented here, each individual plaque was evaluated independently for
comparison of manual and semi-automated methods. Semi-automated measurements for all plaques were repeated five
times by a single observer who was blinded to study subject identity and for each segmentation round, the order of
subjects and plaques was randomized. Semi-automated measurements were compared to manual segmentations using
linear regression and Bland Altman Analysis. For an estimation of intra-observer variability, the coefficient of variation
(CV) for each plaque was generated (standard deviation of five independent measurements divided by the mean) based
on five repeated semi-automated measurements.

3. RESULTS
A single observer identified and measured 22 atherosclerotic plaques within 1.5 cm of the carotid bifurcation (1.0 cm
distal to bifurcation in common carotid artery and 0.5cm proximal to bifurcation in internal carotid artery) in 10
different subject images (4 left carotid artery and 6 right carotid artery). Figure 3 provides images of representative
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segmentation contours generated for manual (red) and semi-automated (yellow) measurement methods in the axial (A)
and longitudinal (B) views. The mean TPV measured using the semi-automated measurement 43±40 mm3 was not
significantly different than the mean TPV obtained using manual measurements 48±46 mm3 (p = 0.60). Table 1 shows
manual and semi-automated mean plaque volume and repeated measures CV for the semi-automated measurements.

Figure 3. Representative manual and semi-automated segmentation boundaries. (A) axial view, (B) longitudinal view. Manual
(red) algorithm contours (yellow). Yellow bar=10mm.
Table 1. Semi-automated and manual measurements for 22 carotid plaques.

Plaque
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
Mean

Semi-automated
Plaque Volume
3
mm (±SD)
18.7±3.7
43.6±4.6
7.9±1.2
4.9±0.7
77.7±10.2
30.6±2.0
2.5±0.4
119.5±11.4
139.5±11.1
67.5±3.8
34.6±3.0
72.3±4.5
15.4±2.2
20.9±2.9
12.2±1.9
2.0±0.5
42.6±1.8
35.4±3.4
26.7±2.8
21.6±2.3
121.4±11.6
21.3±3.1
42.7±40.4

Mean Semiautomated Plaque
Volume
Segmentation Time
(min)
2.1±0.8
3.9±2.5
2.5±1.3
2.8±2.2
3.4±1.6
3.5±1.2
1.6±0.6
3.4±1.7
4.6±3.1
2.4±0.5
1.8±0.4
3.1±2.1
2.7±1.0
2.2±1.0
1.4±0.2
2.2±0.6
2.3±0.6
2.3±0.4
2.7±1.4
2.6±0.8
3.6±1.5
2.0±0.7
2.7±0.8

Manual
Plaque
Volume
3
(mm )
23.2
44.8
7.5
4.9
87.3
37.4
4.5
137.5
145.4
78.5
41.6
72.4
20.5
24.9
10.8
2.0
34.6
35.0
26.8
34.5
151.4
26.0
47.8±45.6

Manual Plaque
Volume
Segmentation
Time (min)
4.1
4.8
2.9
2.8
6.0
6.3
3.9
4.5
4.3
3.9
3.2
4.1
3.0
3.1
3.0
2.3
2.9
3.0
3.2
4.4
5.7
5.0
3.9±1.1

CV Semiautomated
(%)
19.6
10.6
14.6
14.7
13.1
6.5
17.6
9.6
8.0
5.6
8.7
6.3
14.5
13.7
15.2
26.6
4.3
9.7
10.4
10.7
9.6
14.5
12.0±5.1
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Mean Semi-automated Plaque Volume (mm3)

Figure 4 shows the relationship between variability (using CV of each plaque measurement) and mean plaque volume
(left) and the relationship between manual and semi-automated measurements (right). The mean coefficient of variation
for all plaques measured with the semi-automated method was 12±5%. Manual TPV segmentations were significantly
correlated with semi-automated measurements (r = 0.99, p < 0.0001). Semi-automated TPV segmentation was 2.7±0.8
minutes compared to 3.9±1.1 minutes for manual TPV measurements.
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Figure 4. Relationship of semi-automated plaque volume and variability of measurement (CV) (left) Relationship between manual
and Semi-automated measurements (right).

Figure 5 shows Bland Altman analysis of manual compared to semi-automated TPV measurements.
difference between semi-automated and manual measurements was represented as a bias of -11.8 %.
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Figure 5. Bland-Altman Analysis of Agreement between manual and semi-automated TPV. Percent difference between mean
semi-automated TPV measurement (SATPV) and manual total plaque volume measurement (MTPV) plotted against the average of
both measurements. Limits of agreement within two standard deviations are shown with dotted lines.

4. NEW OR BREAKTHROUGH WORK TO BE PRESENTED
We developed a semi-automated measurement of carotid atherosclerotic plaque volume for real-time measurements at
the bedside. Variability of the semi-automated measurement was similar to manual segmentation methods reported by
Landry even for plaques in the 50-100mm3 range, more common in moderate disease without stenosis13. Bland Altman
and linear regression analysis indicated a bias in semi-automated measurements underestimating manual total plaque
volumes. On average, plaque volume was underestimated by approximately 12%.

5. CONCLUSIONS
We developed a semi-automated segmentation tool to measure 3DUS TPV. The geometric volume approximation this
tool provides may provide a more accurate estimate compared to edge detection methods because signal void and
artifacts, common in 3DUS carotid images would not influence contour shape and plaque morphology using a
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geometric method. Although the semi-automated measurement of TPV provided an underestimated measurement in
comparison with manual TPV, this bias may not be clinically significant in longitudinal comparisons. The
measurement tool we developed provided a way to estimate plaque burden in real time at the bedside. Next steps
include the evaluation of inter-observer variability enabling multiple observers to perform measurements in real-time to
monitor carotid atherosclerosis.
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